DK2382310T3 - Polypeptider med xylanaseaktivitet - Google Patents

Polypeptider med xylanaseaktivitet Download PDF

Info

Publication number
DK2382310T3
DK2382310T3 DK09834136.5T DK09834136T DK2382310T3 DK 2382310 T3 DK2382310 T3 DK 2382310T3 DK 09834136 T DK09834136 T DK 09834136T DK 2382310 T3 DK2382310 T3 DK 2382310T3
Authority
DK
Denmark
Prior art keywords
polypeptide
amino acid
xylanase
seq
acid sequence
Prior art date
Application number
DK09834136.5T
Other languages
English (en)
Inventor
Jens Frisbã¦K Sã¿Rensen
Ole Sibbesen
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK2382310T3 publication Critical patent/DK2382310T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477Hemicellulases not provided in a preceding group
    • C12N9/248Xylanases
    • C12N9/2482Endo-1,4-beta-xylanase (3.2.1.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Claims (10)

  1. POLYPEPTIDER MED XYLANASEAKTIVITET
    1. Polypeptid, der har xylanaseaktivitet og omfatter en aminosyresekvens, hvilken aminosyresekvens er mindst 75 % identisk med aminosyresekvensen ifølge SEQ ID NO: 1, og hvilket polypeptid har i) én eller to aminosyremodifikationer i en position, der er udvalgt fra: 12 og 13; og ii) én eller flere yderligere aminosyresubstitutioner i en position, der er udvalgt fra: 15, 34, 54, 77, 81, 82, 99, 104,110, 113, 114,118, 122, 141, 154, 159, 162,164, 166, 175 og 179, hvor positionerne er bestemt som positionen, der svarer til positionen af B. subtilis-xylanasesekvensen ifølge SEQ ID NO: 1 ved alignment; hvor aminosyremodifikationen i position 12 og 13 er en aminosyresubstitution med tyrosin.
  2. 2. Polypeptid ifølge krav 1, der omfatter én eller flere aminosyresubstitutioner, der er udvalgt fra gruppen bestående af: 13Y, 15Y, 34K, 77V, 77M, 77Y, 77L, 77S, 811, 821, 99Y, 104W, 110A, 113D, 113A, 114F, 114D, 114Y, 118V, 122F, 122D, 154R, 159D, 162E, 162D, 164F, 166F, 175L, 175K, 175E, 175Y og 179Y, hvilken eller hvilke positioner bestemmes som den tilsvarende position af B. subtilis -aminosyresekvensen ifølge SEQ ID NO: 1.
  3. 3. Polypeptid ifølge et hvilket som helst af kravene 1-2, hvor polypeptidet er mindst 80, 85, 90, 95 eller 98 % identisk med den sekvens, med hvilken den har den højeste procentvise identitet, der er udvalgt fra SEQ ID NO: 1.
  4. 4. Polypeptid ifølge et hvilket som helst af kravene 1-3, der har en β-jelly roll-fold.
  5. 5. Polypeptid ifølge et hvilket som helst af kravene 1-4, hvilket polypeptid har et samlet antal aminosyrer på mindre end 250, såsom mindre end 240, såsom mindre end 230, såsom mindre end 220, såsom mindre end 210, såsom mindre end 200 aminosyrer, såsom i intervallet på mellem 160 til 240, såsom i intervallet på mellem 160 til 220 aminosyrer.
  6. 6. Polypeptid ifølge et hvilket som helst af kravene 1-5, hvilket polypeptid omfatter én eller flere aminosyresubstitutioner, der er udvalgt fra gruppen bestående af: 13Y, 110A, 122D, 113A, 13Y, 113D, 175L, 122F, 34K, 99Y, 104W, 154R, 159D, 175K, 811, 166F, 162E, 162D, 164F, 114D, 114Y, 114F, 118V, 175K, 77L, 77M, 77S, 77V og 77Y, hvilken eller hvilke positioner bestemmes som den tilsvarende af B. -aminosyresekvensen ifølge SEQ ID NO: 1.
  7. 7. Fremgangsmåde til fremstilling af et polypeptid ifølge et hvilket som helst af kravene 1-6, hvilken fremgangsmåde omfatter ekspression af en nukleotidsekvens, der koder for polypeptidet, og eventuelt isolering af og/eller oprensning af polypeptidet efter ekspression.
  8. 8. Nukleotidsekvens, der koder for et polypeptid ifølge et hvilket som helst af kravene 1-6.
  9. 9. Sammensætning, der omfatter polypeptidet ifølge et hvilket som helst af kravene 1-6, eller polypeptid fremstillet ifølge krav 7 eller nukleotidsekvens ifølge krav 8 sammenblandet med en ikke-toksisk bestanddel.
  10. 10. Anvendelse af polypeptidet ifølge et hvilket som helst af kravene 1-6 eller et polypeptid, der er fremstillet ifølge krav 7, eller nukleotidsekvensen ifølge krav 8 sammenblandet med en ikke-toksisk bestanddel eller sammensætning ifølge krav 9 i en fremgangsmåde til modificering af plantematerialer.
DK09834136.5T 2008-12-23 2009-12-23 Polypeptider med xylanaseaktivitet DK2382310T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08172755 2008-12-23
US14617009P 2009-01-21 2009-01-21
PCT/DK2009/050352 WO2010072225A1 (en) 2008-12-23 2009-12-23 Polypeptides with xylanase activity

Publications (1)

Publication Number Publication Date
DK2382310T3 true DK2382310T3 (da) 2016-12-12

Family

ID=40494933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09834136.5T DK2382310T3 (da) 2008-12-23 2009-12-23 Polypeptider med xylanaseaktivitet

Country Status (13)

Country Link
US (2) US8765438B2 (da)
EP (1) EP2382310B1 (da)
JP (2) JP2012513207A (da)
KR (1) KR20110117663A (da)
CN (1) CN102300985A (da)
AU (1) AU2009329608B2 (da)
CA (1) CA2747224C (da)
DK (1) DK2382310T3 (da)
EA (1) EA201170879A1 (da)
ES (1) ES2602792T3 (da)
MX (2) MX347545B (da)
UA (1) UA103215C2 (da)
WO (1) WO2010072225A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3444343B1 (en) 2008-12-23 2020-10-28 DuPont Nutrition Biosciences ApS Polypeptides
PL2756078T3 (pl) 2011-09-14 2017-12-29 Dupont Nutrition Biosciences Aps Kompozycje zawierające enzymy o aktywności endo-1,4-beta-ksylanazy i enzymy o aktywności endo-1, 3(4)-beta glukanazy
AU2012387042A1 (en) 2012-08-03 2015-02-19 Dupont Nutrition Biosciences Aps Enzymes
WO2014061763A1 (ja) * 2012-10-19 2014-04-24 独立行政法人産業技術総合研究所 新規キシラナーゼ
WO2014140165A1 (en) 2013-03-14 2014-09-18 Dsm Ip Assets B.V. Cell wall deconstruction enzymes of paecilomyces byssochlamydoides and uses thereof
WO2014140167A1 (en) 2013-03-14 2014-09-18 Dsm Ip Assets B.V. Cell wall deconstruction enzymes of malbranchea cinnamomea and uses thereof
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
GB201401699D0 (en) * 2014-01-31 2014-03-19 Dupont Nutrition Biosci Aps Protein
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
EP3017706A1 (en) 2014-11-05 2016-05-11 Dupont Nutrition Biosciences ApS Enzymes for malting
US20190098920A1 (en) 2015-03-04 2019-04-04 Dupont Nutrition Biosciences Aps Cereal grain processing
JP7103948B2 (ja) 2016-03-04 2022-07-20 ダニスコ・ユーエス・インク 微生物におけるタンパク質産生のための遺伝子操作されたリボソームプロモーター
EP3703661A1 (en) 2017-11-02 2020-09-09 Danisco US Inc. Freezing point depressed solid matrix compositions for melt granulation of enzymes
CN109971737B (zh) * 2017-12-28 2020-11-06 中粮集团有限公司 木聚糖酶HoXyn11A的突变体及其制备方法和用途
KR20230062151A (ko) * 2021-10-29 2023-05-09 씨제이제일제당 (주) 자일라나제 활성을 갖는 변이형 폴리펩티드
CA3234382A1 (en) 2021-11-09 2023-05-19 Tina Ploss Improved xylanases
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
KR20230167903A (ko) * 2022-06-03 2023-12-12 씨제이제일제당 (주) 자일라나제 활성을 갖는 변이형 폴리펩티드

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226528A1 (de) 1992-08-11 1994-02-17 Roehm Gmbh Batterien-Xylanase, Verfahren zu ihrer Herstellung sowie dafür geeigneter Bakterienstamm, Plasmid mit zugehörigem Strukturgen, sowie Backmittel und Backverfahren zur Herstellung von Brot und Backwaren unter Verwendung der Xylanase
EP0805856B2 (en) 1995-01-26 2009-04-01 Novozymes A/S Animal feed additives comprising xylanase
US6682923B1 (en) * 1999-05-12 2004-01-27 Xencor Thermostable alkaliphilic xylanase
AU785107C (en) * 2000-03-08 2007-05-03 Dupont Nutrition Biosciences Aps Xylanase variants having altered sensitivity to xylanase inhibitors
EP1184460A1 (en) * 2000-08-29 2002-03-06 Dsm N.V. Modified fungal xylanases
GB0121387D0 (en) 2001-09-04 2001-10-24 Danisco Modified hydrolases
EP2314698A1 (en) * 2002-06-14 2011-04-27 Verenium Corporation Xylanases, nucleic acids encoding them and methods for making and using them
WO2005108565A2 (en) 2003-09-15 2005-11-17 Genencor International, Inc. Modified xylanase, methods of making and use thereof
CN1981036A (zh) * 2003-12-19 2007-06-13 辛根塔参与股份公司 微生物表达的木聚糖酶及其作为饲料添加剂的用途和其他用途
JP2007527726A (ja) * 2004-03-08 2007-10-04 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 自己プロセシング植物および植物部分
CN101023173B (zh) * 2004-03-25 2012-08-08 埃欧金生物制品公司 呈现出增加表达的修饰型木聚糖酶
EP2548955A1 (en) 2006-02-14 2013-01-23 Verenium Corporation Xylanases, nucleic acids encoding them and methods for making and using them
WO2010072226A1 (en) 2008-12-23 2010-07-01 Danisco A/S Polypeptides with xylanase activity
EP3444343B1 (en) 2008-12-23 2020-10-28 DuPont Nutrition Biosciences ApS Polypeptides

Also Published As

Publication number Publication date
EP2382310B1 (en) 2016-08-24
AU2009329608A1 (en) 2011-07-07
CA2747224A1 (en) 2010-07-01
MX2011006640A (es) 2011-07-29
EP2382310A1 (en) 2011-11-02
UA103215C2 (uk) 2013-09-25
US20120028306A1 (en) 2012-02-02
WO2010072225A1 (en) 2010-07-01
ES2602792T3 (es) 2017-02-22
AU2009329608B2 (en) 2013-12-05
US8765438B2 (en) 2014-07-01
JP2012513207A (ja) 2012-06-14
MX347545B (es) 2017-05-02
US20150024466A1 (en) 2015-01-22
US9297002B2 (en) 2016-03-29
CA2747224C (en) 2019-09-03
EP2382310A4 (en) 2012-08-22
JP2015163070A (ja) 2015-09-10
EA201170879A1 (ru) 2012-02-28
CN102300985A (zh) 2011-12-28
KR20110117663A (ko) 2011-10-27

Similar Documents

Publication Publication Date Title
US9249403B2 (en) Polypeptides with xylanase activity
DK2382310T3 (da) Polypeptider med xylanaseaktivitet
US8623629B2 (en) Polypeptides with xylanase activity
CA2399700C (en) Xylanase variants having altered sensitivity to xylanase inhibitors
US10253304B2 (en) Composition and methods comprising a xylanase enzyme variant
ES2845202T3 (es) Polipéptidos